Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88


Mortality and recurrence patterns of breast cancer patients diagnosed under a screening programme versus comparable non-screened breast cancer patients from the same population: analytical survey from 2002 to 2012.

García Fernández A, Chabrera C, García Font M, Fraile M, Lain JM, Gónzalez S, Corral C, Torras M, Torres J, Teixido M, Barco I, López R, Gónzalez C, Pessarrodona A, Giménez N.

Tumour Biol. 2014 Mar;35(3):1945-53. doi: 10.1007/s13277-013-1260-7. Epub 2013 Oct 9.


Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.

Morrell S, Taylor R, Roder D, Robson B, Gregory M, Craig K.

Br J Cancer. 2017 Mar 14;116(6):828-839. doi: 10.1038/bjc.2017.6. Epub 2017 Feb 9.


[Tailored Breast Screening Trial (TBST)].

Paci E, Mantellini P, Giorgi Rossi P, Falini P, Puliti D; TBST Working Group.

Epidemiol Prev. 2013 Jul-Oct;37(4-5):317-27. Italian.


A failure analysis of invasive breast cancer: most deaths from disease occur in women not regularly screened.

Webb ML, Cady B, Michaelson JS, Bush DM, Calvillo KZ, Kopans DB, Smith BL.

Cancer. 2014 Sep 15;120(18):2839-46. doi: 10.1002/cncr.28199. Epub 2013 Sep 9.


Mammography screening in the county of Fyn. November 1993-December 1999.

Njor SH, Olsen AH, Bellstrøm T, Dyreborg U, Bak M, Axelsson C, Graversen HP, Schwartz W, Lynge E.

APMIS Suppl. 2003;(110):1-33.


Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.

Zahl PH, Gøtzsche PC, Mæhlen J.

Lancet Oncol. 2011 Nov;12(12):1118-24. doi: 10.1016/S1470-2045(11)70250-9. Epub 2011 Oct 11.


The cumulative risk of false-positive results in the Norwegian Breast Cancer Screening Program: updated results.

Roman M, Hubbard RA, Sebuodegard S, Miglioretti DL, Castells X, Hofvind S.

Cancer. 2013 Nov 15;119(22):3952-8. doi: 10.1002/cncr.28320. Epub 2013 Aug 20.


Breast cancer mortality in organised mammography screening in Denmark: comparative study.

Jørgensen KJ, Zahl PH, Gøtzsche PC.

BMJ. 2010 Mar 23;340:c1241. doi: 10.1136/bmj.c1241.


Balancing harms and benefits of service mammography screening programs: a cohort study.

Puliti D, Miccinesi G, Zappa M, Manneschi G, Crocetti E, Paci E.

Breast Cancer Res. 2012 Jan 9;14(1):R9.


Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study.

Duffy SW, Mackay J, Thomas S, Anderson E, Chen TH, Ellis I, Evans G, Fielder H, Fox R, Gui G, Macmillan D, Moss S, Rogers C, Sibbering M, Wallis M, Warren R, Watson E, Whynes D, Allgood P, Caunt J.

Health Technol Assess. 2013 Mar;17(11):vii-xiv, 1-95. doi: 10.3310/hta17110.


Does breast screening offer a survival benefit? A retrospective comparative study of oncological outcomes of screen-detected and symptomatic early stage breast cancer cases.

Újhelyi M, Pukancsik D, Kelemen P, Kovács E, Kenessey I, Udvarhelyi N, Bak M, Kovács T, Mátrai Z.

Eur J Surg Oncol. 2016 Dec;42(12):1814-1820. doi: 10.1016/j.ejso.2016.06.403. Epub 2016 Jul 9.


Toward the breast screening balance sheet: cumulative risk of false positives for annual versus biennial mammograms commencing at age 40 or 50.

Winch CJ, Sherman KA, Boyages J.

Breast Cancer Res Treat. 2015 Jan;149(1):211-21. doi: 10.1007/s10549-014-3226-x. Epub 2014 Dec 5.


Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based study.

Nederend J, Duijm LE, Voogd AC, Groenewoud JH, Jansen FH, Louwman MW.

Breast Cancer Res. 2012 Jan 9;14(1):R10.


Clinical outcomes of modelling mammography screening strategies.

Yaffe MJ, Mittmann N, Lee P, Tosteson AN, Trentham-Dietz A, Alagoz O, Stout NK.

Health Rep. 2015 Dec;26(12):9-15.


The natural history of invasive breast cancers detected by screening mammography.

Zahl PH, Maehlen J, Welch HG.

Arch Intern Med. 2008 Nov 24;168(21):2311-6. doi: 10.1001/archinte.168.21.2311.


Effectiveness of Digital Breast Tomosynthesis Compared With Digital Mammography: Outcomes Analysis From 3 Years of Breast Cancer Screening.

McDonald ES, Oustimov A, Weinstein SP, Synnestvedt MB, Schnall M, Conant EF.

JAMA Oncol. 2016 Jun 1;2(6):737-43. doi: 10.1001/jamaoncol.2015.5536. Erratum in: JAMA Oncol. 2016 Apr;2(4):549.


Impact of the transition from screen-film to digital screening mammography on interval cancer characteristics and treatment - a population based study from the Netherlands.

Nederend J, Duijm LE, Louwman MW, Coebergh JW, Roumen RM, Lohle PN, Roukema JA, Rutten MJ, van Steenbergen LN, Ernst MF, Jansen FH, Plaisier ML, Hooijen MJ, Voogd AC.

Eur J Cancer. 2014 Jan;50(1):31-9. doi: 10.1016/j.ejca.2013.09.018. Epub 2013 Oct 25.


Supplemental Content

Support Center